#ChemoCentryx Inc (CCXI)

The Market May be Plummeting But Prohost Picks are Not Biotech stocks had a strong start, but the gains disappeared in many stocks as the market demonstrated bearishness following a long-lasting rally...

ChemoCentryx (CCXI)  develops new drugs for inflammatory, autoimmune diseases and cancers. The firm’s approach comprises targeting the chemokine and chemoattractant systems with the aim of discovering...

THE ROUND  TABLE   DISCUSSION THE RESULTS CLDX   90%;  CMRX  70%;   FOLD 60%;   CCXI 50%; CUR 50%;  IMMU  0%; CEMP 0%; ADHD 0% It was clear that the votes went to  Celldex (CLDX)  as a current investm...

In an effort to find additional small biotech firms with solid scientific fundamentals and products that promise reaching beyond the limiting horizon, we pinpointed ten to date. We picked them from am...

REACHING BEYOND THE HORIZON Courageous scientist-entrepreneurs established the biotech industry. As a matter of fact, the pioneers were more than mere scientists and entrepreneurs. They were ambitious...